MR 409 is a selected growth hormone-releasing hormone (GHRH) agonist. MR 409 has remarkable neuroprotective effects through enhancing endogenous neurogenesis in cerebral ischemic mice. MR 409 also inhibits the in vivo growth of lung cancer[1][2][3][4].
Molecular Weight:
3395.91
Purity:
99.51
CAS Number:
[1445155-39-4]
Formula:
C153H252N44O43
Target:
GHSR
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted